LunaVax

From Innovation to Immunity

Together, let’s Be Lunacious and rewrite the story of global health.

MAP patch white

Vaccine Patches: Painless, Powerful, Needle-Free

We work alongside vaccine developers to bring needle-free vaccine patches to underserved areas, starting with a planned measles-rubella patch study in Nigeria. Our long-term goals include expanding to vaccines such as HPV, national integration and local production. Learn more about microneedle patches from Gavi.

 

Best friends wearing smart casual attire gathering in circle and stacking hands, celebrating friendship and unity, bonding outdoors

Partner with LunaVax to advance vaccine access

LunaVax is advancing vaccine access in Africa by testing how new platforms perform where they’re needed most, from microneedle patches to biometric verification through LunaChain. We work with health facilities, developers and funders to close the gap between innovation and routine care. Partner with LunaVax.

A joyful black boy sits on his mother's lap during a medical consultation as the doctor engages them in conversation, ensuring a soothing healthcare environment.

MR-MAP Study Sites: Lagos, Abuja, Adamawa & Anambra

We’re inviting health facilities across four states to help shape our planned measles-rubella patch study, combining needle-free delivery with biometric verification to strengthen vaccine records in Nigeria. Study design developed through the Harvard Medical School GCSRT. Express interest as a study site.

News and Insights

Vaccine Patches: From trial to routine care.

 

6

Vaccine patches need more than clinical evidence to reach routine care. LunaVax is generating the implementation evidence Nigeria needs. Read the full story → 

 

Stay updated on our latest work in vaccine innovation, partnerships and funding.